Psychedelic Medicines and non-communicable diseases

The European Commission is working on a new ‘Healthier Together’ – EU Non-communicable diseases initiative to support EU countries in reducing the burden of NCDs, focusing on 5 key areas, including mental and neurological disorders. PAREA contributed to this initiative by making a detailed submission as part of the stakeholder consultations.

Previous
Previous

A New European Innovation Agenda

Next
Next

PAREA invited to speak at Psychedelic Capital 2022